Asthma and Allergy Screening AA2000 (Cross Sectional)

Sponsor
Bispebjerg Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04727112
Collaborator
(none)
493
48

Study Details

Study Description

Brief Summary

Asthma screening of 493 asthma patients

Condition or Disease Intervention/Treatment Phase
  • Drug: Usual care versus primary care

Detailed Description

Questionnaire, and testing

Study Design

Study Type:
Observational
Actual Enrollment :
493 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Asthma and Allergy Screening AA2000 (Cross Sectional)
Study Start Date :
Jan 1, 2000
Actual Primary Completion Date :
Jan 1, 2003
Actual Study Completion Date :
Jan 1, 2004

Arms and Interventions

Arm Intervention/Treatment
asthma and rhinitis

Screening of patients with upper and lower airway symptoms

Drug: Usual care versus primary care
RCT study
Other Names:
  • RCT study, usuar care in specialist setting (GINA and ARIA)
  • asthma and rhintis follow-up

    same Group as screened in 2000, was followed up three years later

    Drug: Usual care versus primary care
    RCT study
    Other Names:
  • RCT study, usuar care in specialist setting (GINA and ARIA)
  • Outcome Measures

    Primary Outcome Measures

    1. ACQ [2004]

      Questionnaire based

    2. AQLQ [2004]

      Questionnaire based

    Secondary Outcome Measures

    1. FEV1 [2004]

      Lung function

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria: respiratory symptoms suggestive for asthma -

    Exclusion Criteria:COPD

    -

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Bispebjerg Hospital

    Investigators

    • Principal Investigator: Vibeke Backer, MD, Bispebjerg Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vibeke Backer, Professor, Bispebjerg Hospital
    ClinicalTrials.gov Identifier:
    NCT04727112
    Other Study ID Numbers:
    • asthma and allergy screening
    First Posted:
    Jan 27, 2021
    Last Update Posted:
    Jan 27, 2021
    Last Verified:
    Jan 1, 2021
    Keywords provided by Vibeke Backer, Professor, Bispebjerg Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 27, 2021